Article
Application and mechanism of anticancer peptides in organoid models of intrahepatic cholangiocarcinoma
2025-02-17
Abstract excerpt
<h4>ABSTRACT</h4> <h4>Background</h4> The clinical manifestations of intrahepatic cholangiocarcinoma (ICC) are non-specific, and only a small number of patients are eligible for surgical resection at the time of diagnosis, limiting treatment options. Anticancer peptides (ACPs) exhibit strong inhibitory activity against tumour cell lines, exhibit minimal side effects, are easily modified and optimised, and have l...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- ec42e900-367f-5c35-adb2-e41151f8a0fd
- DOI
- 10.1101/2025.02.17.638575
